08071931120

BHOOMI MARKETING CO.
GST : 24AAJFB4485D1ZL

Our Products

Fresenius Kabi Parental Nutrition

Fresenius Kabi- Enternal Diet

Fresenius Kabi Standard Solution

Fresenius Kabi I.V. Drugs

Fresenius Kabi Nephro

Reliance Life Science

AbcixiRel

Get a Price/Quote

AbcixiRel Specification

Appearance
Clear colorless to slightly yellow liquid.

Weight
Approximately 50 grams per vial including packaging

Feature
High efficacy in reducing thrombotic complications during interventional cardiovascular treatments.

Precautions
Should be used under strict medical supervision; contraindicated in patients with bleeding disorders recent surgery or hypersensitivity to abciximab.

Lead Time
2-3 weeks

Composition
Each vial contains 10 mg of abciximab solution.

Color
Colorless to slightly yellow

Product Type
Pharmaceutical Product

Ingredients
Abciximab

Physical Form
Liquid

Treatments & Functions
Used to prevent blood clots during cardiovascular procedures like angioplasty; helps in reducing the risk of complications during such procedures.

Recommended For

Age Group
Adults

Dosage Guidelines
Administered intravenously by healthcare professionals following the prescribed dose based on body weight and procedure type.

Quantity
10 ml per vial

Packaging
Sterile glass vials individually packed in protective cartons.

Storage Instructions
Store at 2C to 8C (refrigerated); do not freeze. Protect from light.

About AbcixiRel

We have become the profound supplier in the pharmaceutical industry by offering a wide stock of AbcixiRel. We procure this medicine from the recognized vendors of the market. These are hygienically formulated by using best quality compounds. This medicine is indicated for prevention of cardiac ischaemic complications and act as an adjunct to percutaneous coronary intervention. Our AbcixiRel is largely supplied to the hospitals, chemist shops, clinic and nursing homes.

Features:

High effectiveness
Safe to consume
Longer shelf life

Function and Application

AbcixiRel acts as a potent inhibitor to prevent thrombotic events during cardiovascular procedures such as angioplasty. Its use in PCI helps reduce complications related to blood clot formation, offering crucial benefits particularly for patients at heightened risk during interventional treatments.

Packaging and Storage

Each vial of AbcixiRel is securely packed in a sterile glass container and further protected by a carton. For optimal stability and potency, it should be stored in a refrigerator (2C to 8C), not frozen, and shielded from direct light, ensuring it remains ready for clinical use.

Recommended Use and Administration

AbcixiRel is exclusively recommended for adult patients undergoing cardiovascular procedures like PCI. It is administered intravenously under strict medical supervision, with dosage carefully calculated by healthcare professionals according to the patients body weight and type of procedure performed.

FAQs of AbcixiRel:

Q: How is AbcixiRel used during cardiovascular procedures?

A: AbcixiRel is administered intravenously by healthcare professionals during procedures such as PCI or angioplasty. It helps prevent blood clot formation, thereby reducing potential complications associated with these treatments.

Q: What is the recommended dosage and who determines it for AbcixiRel?

A: The specific dosage of AbcixiRel is calculated based on the patients body weight and the type of cardiovascular procedure. Only qualified healthcare professionals determine and administer the appropriate amount to ensure both safety and efficacy.

Q: When should AbcixiRel be given to a patient?

A: AbcixiRel is administered just before or during cardiovascular interventions, such as percutaneous coronary intervention, according to established medical protocols to maximize its benefit in preventing thrombotic events.

Q: Where should AbcixiRel be stored before use?

A: The product must be kept refrigerated at temperatures between 2C and 8C. It should also be protected from light and never frozen to maintain its stability and effectiveness.

Q: What benefits does AbcixiRel provide for patients undergoing PCI?

A: AbcixiRel significantly reduces the likelihood of blood clot-related complications during and after interventional cardiovascular procedures, improving patient safety and procedural outcomes.

Q: What precautions must be followed when using AbcixiRel?

A: Use of AbcixiRel requires strict medical supervision and is contraindicated in individuals with bleeding disorders, recent surgery, or known hypersensitivity to abciximab. Healthcare providers assess suitability before administration.

Q: How is AbcixiRel packaged for distribution?

A: Each 10 ml vial of AbcixiRel is packed in a sterile glass container and further enclosed in a protective carton to maintain product integrity during storage and transport.

Tell us about your requirement